The key equity indices traded with substantial losses in morning trade. The Nifty slipped below the 24,700 level. Metal shares extended losses for the second consecutive trading sessions.
At 10:29 IST, the barometer index, the S&P BSE Sensex, declined 352.40 points or 0.43% to 81,780.72. The Nifty 50 index lost 98.25 points or 0.40% to 24,670.05.
The broader market outperformed the frontline indices. The S&P BSE Mid-Cap index added 0.31% and the S&P BSE Small-Cap index rose 0.38%.
The market breadth was strong. On the BSE, 2,313 shares rose and 1,483 shares fell. A total of 155 shares were unchanged.
Economy:
India's foreign exchange reserves dropped by $3.235 billion to $654.857 billion, a five-month low, for the week ended December 6, data released by the Reserve Bank of India (RBI) revealed on Friday.
Foreign currency assets, a major component of the reserves, decreased by $3.228 billion to $565.623 billion for the week ended December 6, 2024, as per the data.
Meanwhile, gold reserves dropped by $43 million to $66.936 billion in the week under consideration. The Special Drawing Rights (SDRs) increased by $25 million to $18.031 billion, RBI data showed.
India's reserve position with the IMF rose by $12 million to $4.266 billion in the reporting week.
Buzzing Index:
The Nifty Metal index slipped 0.98% to 9,347.10. The index fell 1.68% in past two consecutive trading sessions.
Jindal Steel & Power (down 1.79%), Vedanta (down 1.37%), JSW Steel (down 1.19%), Hindustan Copper (down 1.08%), Ratnamani Metals & Tubes (down 1.08%), National Aluminium Company (down 1.04%), NMDC (down 0.88%), Steel Authority of India (down 0.85%), Tata Steel (down 0.60%) and Hindalco Industries (down 0.50%).
Stocks in Spotlight:
JSW Energy advanced 2.09% after the company announced that it has secured multiple renewable energy (RE) projects in the commercial and industrial (C&I) power market.
GE Power India rallied 3.93% after the company announced that it has received an order worth Rs 18.27 crore from MP Power Generating Company (MPPGCL).
Glenmark Pharmaceuticals rose 1.88% after the company announced that its US-based subsidiary, Glenmark Pharmaceuticals Inc., USA, has launched Lacosamide oral solution, in the U.S. market.
Powered by Capital Market - Live News